Tadalafil NDC 16729-369

Product information

Brand name (proprietary)

Tadalafil

Generic name (nonproprietary)

tadalafil

Active ingredients

Tadalafil — 2.5 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Accord Healthcare Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209167

Marketing start

Mar 27, 2019

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 16729-369_4f99c59f-9b38-f54a-e063-6294a90a60eeSPL ID 4f99c59f-9b38-f54a-e063-6294a90a60eeSPL set ID eedf3ad9-7d40-496d-b1a9-6200010c18e1RxCUI 402019, 403957, 484814, 757707UNII 742SXX0ICTUPC 0316729372107, 0316729369107, 0316729370103

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416729036910 followed by a unit qualifier and the quantity Copy

Package 16729-0369-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209167

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.